The CEO, and the entire management team, knows enough about business focus to ignore most of what gets said on retail investor boards. They have a plan. They have shared the plan. They are executing on the plan. I like the plan, and I know that the effects of NR are real and significant (at least for some people), so I am long.
I think the price is low, given the research that has come out. The key study is the one that says oral supplementation does in fact replenish NAD+ levels. Once that is true, the rest is pretty much inevitable. The underlying science and the published research shows a wide range of benefits will follow, for those suffering from NAD+ deficiency.
The only negative study I saw was the one that drowned young rats -- nobody thinks that young rats are short of NAD+, so replenishment should NOT show positive effects. Contrary to what the study's authors concluded, I see it as consistent with the rest of the research showing that NAD+ replenishment has positive effects (and conversely no positive effects would appear when replenishment was not occurring).
News 
Market Data 
Discover 
